title: Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels.
abstract: Both host carbogen (95% oxygen/5% carbon dioxide) breathing and nicotinamide administration enhance tumour radiotherapeutic response and are being re-evaluated in the clinic. Non-invasive magnetic resonance imaging (MRI) and 31P magnetic resonance spectroscopy (MRS) methods have been used to give information on the effects of nicotinamide alone and in combination with host carbogen breathing on transplanted rat GH3 prolactinomas. Gradient recalled echo (GRE) MRI, sensitive to blood oxygenation changes, and spin echo (SE) MRI, sensitive to perfusion/flow, showed large signal intensity increases with carbogen breathing. Nicotinamide, thought to act by suppressing the transient closure of small blood vessels that cause intermittent tumour hypoxia, induced a small increase in blood oxygenation but no detectable change in perfusion/flow. Carbogen combined with nicotinamide was no more effective than carbogen alone. Both carbogen and nicotinamide caused significant increases in the nucleoside triphosphate/inorganic phosphate (betaNTP/Pi) ratio, implying that the tumour cells normally receive sub-optimal substrate supply, and is consistent with either increased glycolysis and/or a switch to more oxidative metabolism. The most striking observation was the marked increase in blood glucose (twofold) induced by both nicotinamide and carbogen. Whether this may play a role in tumour radiosensitivity has yet to be determined.
authors.affiliation: CRC Biomedical Magnetic Resonance Research Group, Division of Biochemistry, St George's Hospital Medical School, London, UK.
authors.forename: S P
authors.initials: SP
authors.lastname: Robinson
authors.forename: F A
authors.initials: FA
authors.lastname: Howe
authors.forename: M
authors.initials: M
authors.lastname: Stubbs
authors.forename: J R
authors.initials: JR
authors.lastname: Griffiths
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000187:drug effects*; D002245:Carbon Dioxide / Q000494:pharmacology*; D004734:Energy Metabolism / Q000187:drug effects*; D005260:Female; D006830:Hydralazine / Q000494:pharmacology; D008279:Magnetic Resonance Imaging; D009536:Niacinamide / Q000494:pharmacology*; D010100:Oxygen / Q000378:metabolism* / Q000494:pharmacology*; D015175:Prolactinoma / Q000098:blood supply / Q000378:metabolism*; D051381:Rats; D011920:Rats, Inbred WF; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D002245:Carbon Dioxide; D009536:Niacinamide; D006830:Hydralazine; C011700:carbogen; D010100:Oxygen